Kadara's clinical review model defines how features are monitored, reviewed, and paused when needed during pilot and rollout.
These are the rules the team and the advisor work by. They are designed to make the review process visible, not theoretical.
Every output is a draft for clinician review. Clinical decisions remain with the licensed provider. The system does not make clinical decisions.
Nothing enters the clinical record without clinician sign-off. There is no auto-finalize, no background commit, no exception.
Changes that affect clinical output are reviewed by the internal team every week. The review covers behavior changes, sample outputs, and flagged cases.
A panel of external clinicians reviews safety, performance, and bias across the pilot. The panel reviews on a fixed cadence and on demand when a clinical-safety concern is raised.
If a clinical-safety concern is reported, related features pause for the affected clinic until the panel reviews. The pause is the default response, not an escalation.
Low-risk features (documentation, summaries, follow-up) ship after internal review. Features that touch clinical decision support require external panel sign-off before they ship.
Advises Kadara on its clinical review model.
Pre-launch, the review model is best discussed directly. We are happy to walk through any commitment in detail.